US Stocks Mixed; Pfizer Earnings Beat Views
Portfolio Pulse from Lisa Levin
US stocks were mixed with Dow Jones trading slightly higher and NASDAQ and S&P 500 falling. Pfizer reported better-than-expected Q2 earnings, beating market estimates. ABVC BioPharma, TG Therapeutics, and Cybin saw their shares rise, while Polished.com, Alset Capital Acquisition, and Silicom saw their shares drop. Oil and gold traded down, while European shares were lower. Asian markets closed mixed.
August 01, 2023 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Shares of Alset Capital Acquisition were down 24%.
The significant drop in Alset Capital Acquisition's shares is likely to continue in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Shares of Polished.com dropped 55%.
The significant drop in Polished.com's shares is likely to continue in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Shares of Silicom were down, falling 25%.
The significant drop in Silicom's shares is likely to continue in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Shares of ABVC BioPharma shot up 68%.
The significant rise in ABVC BioPharma's shares is likely to continue in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Shares of Cybin were up, gaining 28%.
The significant rise in Cybin's shares is likely to continue in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Pfizer reported better-than-expected Q2 earnings, beating market estimates.
Pfizer's better-than-expected earnings report is likely to have a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Shares of TG Therapeutics got a boost, shooting 48% up.
The significant rise in TG Therapeutics' shares is likely to continue in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100